ZA200502325B - Method for producing a 3,5-dihydroxy-6-heptenoate - Google Patents
Method for producing a 3,5-dihydroxy-6-heptenoate Download PDFInfo
- Publication number
- ZA200502325B ZA200502325B ZA200502325A ZA200502325A ZA200502325B ZA 200502325 B ZA200502325 B ZA 200502325B ZA 200502325 A ZA200502325 A ZA 200502325A ZA 200502325 A ZA200502325 A ZA 200502325A ZA 200502325 B ZA200502325 B ZA 200502325B
- Authority
- ZA
- South Africa
- Prior art keywords
- formula
- dole
- eluent
- compound
- flow rate
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- QISVKQXLGLNOTM-ANMDKAQQSA-N methyl (e,3r,5s)-7-[4-(4-fluorophenyl)-5-(hydroxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound COC(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C(C)C)N=C(C(C)C)C(CO)=C1C1=CC=C(F)C=C1 QISVKQXLGLNOTM-ANMDKAQQSA-N 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000741 silica gel Substances 0.000 claims abstract description 17
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 17
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 13
- 238000012856 packing Methods 0.000 claims abstract description 12
- 238000004811 liquid chromatography Methods 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 53
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 51
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 32
- 239000003480 eluent Substances 0.000 claims description 31
- 238000004587 chromatography analysis Methods 0.000 claims description 20
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 17
- 239000012046 mixed solvent Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 239000011148 porous material Substances 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 3
- -1 alkyl (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate Chemical compound 0.000 abstract description 4
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract description 2
- 239000003638 chemical reducing agent Substances 0.000 abstract description 2
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract description 2
- MAUQAXOHCVNUMX-BUHFOSPRSA-N ethyl (e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound CCOC(=O)CC(O)CC(O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 MAUQAXOHCVNUMX-BUHFOSPRSA-N 0.000 description 63
- 238000004128 high performance liquid chromatography Methods 0.000 description 26
- 239000000203 mixture Substances 0.000 description 19
- 239000007788 liquid Substances 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 230000004048 modification Effects 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 5
- 125000004548 quinolin-3-yl group Chemical group N1=CC(=CC2=CC=CC=C12)* 0.000 description 5
- 238000004064 recycling Methods 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000011914 asymmetric synthesis Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- RWZYEKXHAQMRIO-UHFFFAOYSA-N 2,2-dihydroxyhept-6-enoic acid Chemical compound OC(=O)C(O)(O)CCCC=C RWZYEKXHAQMRIO-UHFFFAOYSA-N 0.000 description 1
- YURNCBVQZBJDAJ-UHFFFAOYSA-N 2-heptenoic acid Chemical compound CCCCC=CC(O)=O YURNCBVQZBJDAJ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005575 aldol reaction Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000007273 lactonization reaction Methods 0.000 description 1
- 238000007561 laser diffraction method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002275015 | 2002-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200502325B true ZA200502325B (en) | 2006-11-29 |
Family
ID=32025020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200502325A ZA200502325B (en) | 2002-09-20 | 2003-09-11 | Method for producing a 3,5-dihydroxy-6-heptenoate |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7339062B2 (de) |
| EP (1) | EP1539698B1 (de) |
| JP (1) | JP4501690B2 (de) |
| KR (1) | KR101067314B1 (de) |
| CN (1) | CN100349871C (de) |
| AT (1) | ATE485277T1 (de) |
| AU (1) | AU2003260963B2 (de) |
| CA (1) | CA2499335C (de) |
| DE (1) | DE60334627D1 (de) |
| HK (1) | HK1078854A1 (de) |
| WO (1) | WO2004026838A1 (de) |
| ZA (1) | ZA200502325B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060006052A (ko) * | 2003-04-24 | 2006-01-18 | 다이셀 가가꾸 고교 가부시끼가이샤 | 에틸(3ｒ,5ｓ,6ｅ)-7-[2-시클로프로필-4-(4-플루오로페닐)퀴놀린-3-일]-3,5-디히드록시-6-헵테노에이트의 제조 방법 |
| TWI343914B (en) * | 2003-10-03 | 2011-06-21 | Nissan Chemical Ind Ltd | Process for producing high purity 3,5-dihydroxy-6-heptenoic acid derivative |
| WO2006011047A1 (en) * | 2004-07-23 | 2006-02-02 | Pharmacia & Upjohn Company Llc | Enantioselective method for separing substituted 2-trifluoromethyl-2h-chromene-3-carboxylic acid derivatives |
| CN101955477B (zh) * | 2009-07-21 | 2012-08-29 | 上海医药工业研究院 | 2-环丙基-4-取代苯硫基喹啉类化合物及其中间体、制备方法和应用 |
| US8471030B2 (en) | 2010-12-06 | 2013-06-25 | Orochem Technologies Inc. | Purification of montelukast using simulated moving bed |
| CN112574825A (zh) * | 2020-11-20 | 2021-03-30 | 余海龙 | 一种高纯度不饱和脂肪酸的提取工艺 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3528186B2 (ja) * | 1991-06-24 | 2004-05-17 | 日産化学工業株式会社 | 光学活性キノリンメバロン酸のジアステレオマー塩 |
| KR100355335B1 (ko) * | 1994-02-25 | 2003-04-11 | 다이세루 가가꾸 고오교 가부시끼가이샤 | 광학활성메발로노락톤계화합물의제조방법 |
| EP0687491A1 (de) * | 1994-06-16 | 1995-12-20 | Daicel Chemical Industries, Ltd. | Chromatographisches simuliertes Wanderbetttrennungsverfahren |
| AU2001295926A1 (en) * | 2000-10-13 | 2002-04-22 | Daicel Chemical Industries, Ltd. | Process for producign optically active ethyl |
| US6835838B2 (en) * | 2002-01-28 | 2004-12-28 | Novartis Ag | Process for the manufacture of organic compounds |
-
2003
- 2003-09-11 EP EP03797579A patent/EP1539698B1/de not_active Expired - Lifetime
- 2003-09-11 WO PCT/JP2003/011643 patent/WO2004026838A1/en active Application Filing
- 2003-09-11 KR KR1020057004665A patent/KR101067314B1/ko not_active IP Right Cessation
- 2003-09-11 CN CNB038223333A patent/CN100349871C/zh not_active Expired - Fee Related
- 2003-09-11 AU AU2003260963A patent/AU2003260963B2/en not_active Ceased
- 2003-09-11 ZA ZA200502325A patent/ZA200502325B/en unknown
- 2003-09-11 CA CA2499335A patent/CA2499335C/en not_active Expired - Fee Related
- 2003-09-11 US US10/528,179 patent/US7339062B2/en not_active Expired - Lifetime
- 2003-09-11 DE DE60334627T patent/DE60334627D1/de not_active Expired - Lifetime
- 2003-09-11 JP JP2004537553A patent/JP4501690B2/ja not_active Expired - Fee Related
- 2003-09-11 AT AT03797579T patent/ATE485277T1/de not_active IP Right Cessation
-
2005
- 2005-11-24 HK HK05110674.7A patent/HK1078854A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1539698A1 (de) | 2005-06-15 |
| WO2004026838A1 (en) | 2004-04-01 |
| CN1681790A (zh) | 2005-10-12 |
| CA2499335C (en) | 2010-12-07 |
| DE60334627D1 (de) | 2010-12-02 |
| CA2499335A1 (en) | 2004-04-01 |
| AU2003260963B2 (en) | 2010-06-03 |
| KR101067314B1 (ko) | 2011-09-23 |
| AU2003260963A1 (en) | 2004-04-08 |
| KR20050057443A (ko) | 2005-06-16 |
| HK1078854A1 (en) | 2006-03-24 |
| CN100349871C (zh) | 2007-11-21 |
| JP4501690B2 (ja) | 2010-07-14 |
| US7339062B2 (en) | 2008-03-04 |
| JP2006500405A (ja) | 2006-01-05 |
| EP1539698B1 (de) | 2010-10-20 |
| US20060167260A1 (en) | 2006-07-27 |
| ATE485277T1 (de) | 2010-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5502199A (en) | Process for preparing sodium 3R,5S-(+)-erythro-(E)-7- 4-(4-fluorophenyl)-2,6-diisopropyl-5-methoxymethyl-pyrid-3-yl!-3,5-dihydroxy-hept-6-enoate | |
| EP1073618B1 (de) | Verfahren zur herstellung von enantiomeren reinem oder optisch angereicherter sertraline-tetralon durch kontinuierliche chromatographie | |
| JP2009221209A (ja) | ベンゾオキサジン誘導体の製造法およびその製造中間体 | |
| CA2499335C (en) | Method for producing a 3,5-dihydroxy-6-heptenoate | |
| JP3236282B1 (ja) | プラバスタチンを精製する方法 | |
| HU226863B1 (en) | Process for separation of optical isomers of "corey-lactone" by liquid chromatography | |
| CN108997212B (zh) | 一种匹伐他汀叔丁酯的精制方法 | |
| JP2009520753A (ja) | 純粋な形態のα−キラルクロロメチル化合物の製造方法 | |
| JP5776553B2 (ja) | 酵素を用いた光学活性ビシクロ［３．１．０］ヘキサン誘導体の製造方法 | |
| KR102604613B1 (ko) | 라타노프로스틴 부노드의 제조 방법, 및 그의 중간체, 및 그를 포함하는 조성물 | |
| Guzzo et al. | Preparation of optically active (acyloxy) alkyl esters from optically active O-acyl-α-hydroxy acids | |
| JP3422791B2 (ja) | プラバスタチンの単離・精製方法 | |
| JP3463881B2 (ja) | プラバスタチン又はその薬理上許容される塩の単離・精製方法 | |
| JP3463875B2 (ja) | プラバスタチンを精製する方法 | |
| JP2001213864A (ja) | ラクタムの異性体混合物の異性体分離のための方法ならびにこうして得られた光学対掌体の使用 | |
| JP3210683B2 (ja) | 異性体分離法 | |
| JP2001352996A (ja) | 光学活性化合物の取得方法 | |
| CN101440056A (zh) | 一种多西他赛侧链中间体的拆分方法 |